The company is a high-tech enterprise focusing on the front end of the new drug research and development industry chain, relying on core businesses such as R&D, design, production and sales of pharmaceutical molecular blocks to provide new drug R&D institutions with novel and unique structures, diverse functions, and a rich variety of pharmaceutical molecular components and scientific reagents. The company is an enterprise that provides professional and efficient drug molecular blocks and scientific reagent products and services for new drug research and development institutions. The company's main products include: (1) pharmaceutical molecular blocks, which can be subdivided into heterocyclic compounds, benzene compounds, and aliphatic compounds; (2) scientific reagents: reagents that do not directly participate in the construction of compounds, but are indispensable in the development of new drugs, and can be subdivided into active small molecule compounds, catalysts, and ligands. Corporate honors: Shanghai “Specialized, Special and New” Small and Medium Enterprises in 2020, National Specialized, Special and New “Little Giant” Enterprises in 2021, etc. “Little Giant of Science and Technology in Shanghai” in 2021, “Shanghai Enterprise Technology Center” in 2023, etc.
No Data